The beneficial impact of filtration surgery on antiviral therapy cessation in patients with cytomegalovirus-related secondary glaucoma

Table 3 Clinical parameters of four patients treated without surgery

First visit							Last visit
Sex	Age at first visit, Yrs	Duration from onset to referral to our hospital, Yrs	CMV PCR, copies/mL	LogMAR	IOP, mmHg	ECD, cells/mm²	Follow-up period, Yrs	LogMAR	IOP, mmHg	ECD, cells/mm²	Oral valganciclovir	Topical ganciclovir
F	33	8	1.2 × 10⁴	−0.08	33	2457	4.8	−0.18	13	2075	No	Yes
M	83	6	1.1 × 10²	0.10	14	449	1.9	2.9	18	unmeasurable	No	Yes
M	72	18	4.2 × 10³	0.15	16	2463	5.8	0	10	1855	No	No
M	68	7	8.8 × 10⁴	−0.18	17	2410	4.2	−0.18	16	1792	No	No

CMV Cytomegalovirus, PCR Polymerase chain reaction, IOP Intraocular pressure, ECD Corneal endothelial cells density

ISSN: 1471-2415